Research progress of immunotherapy against anaplastic thyroid cancer
Frontiers in Oncology · 26.03.2024 · 14
DOI: 10.3389/fonc.2024.1365055 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 26.03.2024. Verfasst von Jiaqian Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The First Affiliated Hospital of Yangtze University, Jingzhou, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Anaplastic thyroid cancer (ATC) is the most aggressive type of thyroid cancer. While ATC is rare, its mortality is high. Standard treatments, such as surgery, radiotherapy, and chemotherapy, have demonstrated limited efficacy in managing ATC. However, the advent of immunotherapy has significantly improved the prognosis for patients with ATC. Immunotherapy effectively targets and eliminates tumor cells by using the power of the body’s immune cells. The neoantigen is an atypical protein generated by somatic mutation, is exclusively observed in neoplastic cells, and is devoid of central tolerance. Neoantigens exhibit enhanced specificity towards tumor cells and display robust immunogenic properties. Currently, neoantigen therapy is primarily applied in immune checkpoint inhibitors and cellular immunotherapy, encompassing adoptive immunotherapy and tumor vaccines. This study discusses the mechanism, tumor microenvironment, clinical trials, adverse events, limitations and future directions associated with ATC immunotherapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology, The First Affiliated Hospital of Yangtze University, Jingzhou, China.
Zitieren
APA
Chen, J., Xiao, Z., & Wu, H. (2024). Research progress of immunotherapy against anaplastic thyroid cancer. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1365055
Vancouver
Chen J, Xiao Z, Wu H. Research progress of immunotherapy against anaplastic thyroid cancer. Frontiers in Oncology. 2024;14. doi:10.3389/fonc.2024.1365055
BibTeX
@article{Chen2024,
author = {Chen, Jiaqian and Xiao, Zuixuan and Wu, Hongyan},
title = {Research progress of immunotherapy against anaplastic thyroid cancer},
journal = {Frontiers in Oncology},
year = {2024},
volume = {14},
doi = {10.3389/fonc.2024.1365055}
}
EUVIMED